Hematology

Latest News

FDA
Odronextamab BLA Is Under Priority Review for 2 Lymphoma Indications

October 3rd 2023

The FDA has granted priority review to odronextamab for relapsed/refractory follicular lymphoma and diffuse large B-cell lymphoma.

blood cells
Ambulation Improves Frailty Scores in Patients With Multiple Myeloma

October 2nd 2023

blood cells
PVd Confers a Small OS Benefit to Patients With Relapsed/Refractory Multiple Myeloma

October 1st 2023

Real-World Experiences With Teclistamab Are Comparable To Clinical Trial Reports
Real-World Experiences With Teclistamab Are Comparable To Clinical Trial Reports

September 30th 2023

FDA Approval
Bosutinib Is Approved for Pediatric Ph+ CP–Chronic Myeloid Leukemia

September 27th 2023

Video Interviews
Podcasts
The Vitals
Oncology Nursing News
Oncology Nursing Stories: Pregnancy After Lymphoma Chemoradiation
Stephanie Jackson Unpacks Recent Advances in Leukemia Treatments
When an Oncology Nurse Becomes a Cancer Mom: How One Nurse Navigated Her Child’s Leukemia Diagnosis
Latest CME Events & Activities

Bridging the Care Gap in Anemia in CKD: A Comprehensive Guide to Enhancing Patient Care

Register Now!

Antibody-Drug Conjugates in Gynecological Cancer – Setting the Stage

View More

Anemia of Chronic Kidney Disease: Improving Recognition and Early Treatment in the Primary Care Setting

View More

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

View More

2nd Annual International Congress on Pediatric Oncology

View More

Burst CME: Regulatory Approval Pathways for Influenza Vaccines

View More

4th Annual Virtual Tumor Board®: Diagnosis and Management of Polycythemia Vera and Myelofibrosis

View More

Community Practice Connections™: 23rd Annual International Lung Cancer Congress®

View More

Medical Crossfire®: Experts Address Your Burning Questions on the Evolving Treatment of MF, PV, and ET!

View More

Oncology Consultations®: Leveraging Clinical Data and Trials to Inform Treatment for Patients with PV

View More

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow®

Register Now!

Clinical Vignettes: Charting The Changing Landscape in Multiple Myeloma from Frontline to Relapsed/Refractory Disease

View More

Clinical Interchange™: Improving Outcomes and Overcoming Barriers to Equitable Care in African American Patients With Multiple Myeloma

View More

Community Practice Connections™: 4th annual Precision Medicine Symposium: An Illustrated Tumor Board

View More

PER's Breast Cancer Symposia in San Antonio

Register Now!

2023 Friday Satellite Symposia: Preceding the 65th ASH Annual Meeting and Exposition

Register Now!

Bridging Clinical Gaps in Indolent and Aggressive B-Cell Lymphomas: The Investigators Demonstrate How Novel Mechanisms Will Impact Your Practice Tomorrow

View More

Updates from the Annual Hematology Meeting: Matching the Tumor with Patient Specific Goals to Inform Frontline Selection and Sequencing in Chronic Lymphocytic Leukemia

View More

Oncology Town Hall™: Primary Investigators Present Key Abstracts in the Management of CLL

View More

Clinical ShowCase™ in aHUS: The Application of Complement Inhibitors in Practice

View More

Transfusion-Related Iron Overload–Evidence-Based Approaches to Improve Chelation Outcomes

View More

State-of-the-Art CMV Care: Experts’ Perspectives on Primary/Secondary Prevention and Management of Refractory/Resistant Infections

View More

Follicular Lymphoma Workshop: Forging Patient-Centric Plans with Targeted Therapies Across Lines of Care

View More

Gene Therapy for Hemophilia: What Does the Future Hold?

View More

Sickle Cell Disease: Improving the Quality and Continuum of Acute and Ambulatory Patient Care

View More

Cancer Summaries and Commentaries™: Report from New Orleans on the Latest Updates in the Treatment of MPNs

View More

Medical Crossfire®: How Do We Apply the Latest Evidence on Novel Therapies to Prevent and Treat GVHD?

View More

Medical Crossfire®: How The Experts Treat Acute Lymphoblastic Leukemia: Case Discussions from Adolescent to Adult

View More

"D" is for Diagnosis: Deciphering Uncommon Hematologic Disorders Through the Eyes of a Detective

View More

MRD Assessment as a Cornerstone to Clinical Decision-Making in Hematologic Malignancies: Techniques, Utilization, and Best Practices to Optimize Patient Outcomes

View More

More News

© 2023 MJH Life Sciences

All rights reserved.